Exclusive Report on Global Proteomics Industry: to grow at a whopping rate of CAGR 15.34%

The global Proteomics market size was valued at $27.9 Billion in 2020 and is expected to reach $88.0 Billion by 2028 growing at the CAGR of 15.34% from 2021 to 2028.

Proteomics growth is driven by rise in popularity of personalized medicines, surge in R&D expenditure, and technological advancements associated with proteomics components. Moreover, high costs associated with components and dearth of skilled professionals hamper the market growth. Conversely, lucrative opportunities associated with biomarker identification and developments in mass spectrometry-based proteomics are expected to provide lucrative growth opportunities for the proteomics market growth.

Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=005504

Key Players

Some of the major Proteomics players holding high market share include Thermo Fisher Scientific Inc, Bio-Rad Laboratories, and Merck KGaA. These players use new product development and expansion as a key strategy to gain significant market share to compete with market leaders.

The key players profiled in the report are:
● Thermo Fisher Scientific Inc
● Bio-Rad Laboratories
● Merck KGaA
● Agilent Technologies
● Bruker Corporation
● Danaher Corporation
● GE Healthcare
● Luminex Corporation
● LuPerkinElmer Inc.
● Waters Corporation

The recently published research report on Global Proteomics Market by Evolve Business Intelligence examines the industry in the context of major market aspects including market size & forecast, market shares in terms of revenues and volume, key players, and SWOT analysis. The market is analyzed based on 4 separate indications in the market dynamic chapter: Drivers, Restraints, Key Trends, and Challenges. The total sum of these sections will help you understand what strategies will be best to adopt in order to prosper through this industry over a few short years. The quantitative analysis includes our actual findings out of this research study where we provided additional insight into what our readers can do to embrace new opportunities or plan against threats that might hinder the market.

The COVID-19 pandemic has led to disruption in the supply chain leading to lower demand or supply shortages in the Proteomics market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is expected to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers adopting various strategies to stabilize the company.

The New Normal

As businesses recover from the COVID-19 pandemic, they have a new set of priorities to cope with. Throughout this crisis, they were forced to deal with shifting situations and often fell short of their ultimate goals. Now that a cure has been found and the pandemic is dying down, they will need to recuperate from this epidemic by setting forth new objectives to succeed in the future.

In terms of COVID 19 impact, the Proteomics market report also includes the following data points:
● COVID19 Impact on Proteomics market size
● End-User/Industry/Application Trend, and Preferences
● Government Policies/Regulatory Framework
● Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
● Opportunity in Proteomics market

Segmental Analysis

Market Segment By Component with focus on market share, consumption trend, and growth rate of Proteomics Market:
o Instruments
o Reagents
o Services

Market Segment By Application with the focus on market share, consumption trend, and growth rate of Proteomics Market:
o Drug Discovery
o Diseases Diagnosis

For more information: https://evolvebi.com/product/proteomics-market-analysis-and-global-forecast-2021-2028-with-covid-impact-analysis/

Key Region/ Countries Covered
● North America (US, Canada, Mexico)
● Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
● Asia-Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
● Rest of the World (the Middle East & Africa and South America)

The global protein market is segmented into North America, Europe, the Asia Pacific, Latin America and Middle East & Africa. In 2020, North America accounted for the largest market share in the protein market. This can be attributed to the increasing investments in the development of structure-based drug design, growing research in the field of omics, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics. The presence of a large number of global players in this region is also supporting the growth of this market.

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Contact: +1 773 644 5507 / +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging the pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool – EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune’s global 2000 companies.

This release was published on openPR.